Aripiprazole vs. Lamictal: side effect and effectiveness comparison - a phase IV clinical study
Summary:
We compare the side effects and drug effectiveness of Aripiprazole and Lamictal. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 251,642 people who take Aripiprazole and Lamictal, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
251,642 people who take Aripiprazole and Lamictal are studied.
What is Aripiprazole?
Aripiprazole has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 29,998 Aripiprazole users for its effectiveness, alternative drugs and more.
What is Lamictal?
Lamictal has active ingredients of lamotrigine. It is often used in bipolar disorder. eHealthMe is studying from 77,342 Lamictal users for its effectiveness, alternative drugs and more.
Number of reports submitted per year:
Drugs being compared in this study:
- Lamictal (lamotrigine)
- Aripiprazole (aripiprazole)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Aripiprazole:
- not at all: 7.8 %
- somewhat: 25.77 %
- moderate: 30.1 %
- high: 24.95 %
- very high: 11.39 %
Lamictal:
- not at all: 3.12 %
- somewhat: 16.99 %
- moderate: 31.22 %
- high: 31.56 %
- very high: 17.12 %
Want to compare Aripiprazole with Lamictal?
Personalize this study to your gender and age (0-99+).How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Alonso-Navarro H, Montes JM, Plaza-Nieto JF, Jiménez-Jiménez FJ, "Cataplexy Possibly Associated With Lamotrigine", Journal of clinical psychopharmacology, 2016 Aug .
- Gupta MC, Khanna J, Mathur R, Mittal N, "Lamotrigine-induced fulminant hepatic failure: an unusual presentation", IMSEAR, 2015 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
Related studies
Alternative drugs to, pros and cons of:
- Aripiprazole (29,780 reports)
- Lamictal (69,379 reports)
Common Aripiprazole side effects:
- Drug ineffective: 3,061 reports
- Weight increased: 1,682 reports
- Stress and anxiety: 1,573 reports
- Fatigue (feeling of tiredness): 1,372 reports
- Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1,231 reports
- Agitation (state of anxiety or nervous excitement): 1,095 reports
- Suicidal ideation: 1,043 reports
- Drowsiness: 1,019 reports
Browse all side effects of Aripiprazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Lamictal side effects:
- Rashes (redness): 7,619 reports
- Drug ineffective: 4,306 reports
- Fever: 3,676 reports
- Dizziness: 3,666 reports
- Fatigue (feeling of tiredness): 3,650 reports
- Headache (pain in head): 3,457 reports
- Stress and anxiety: 3,398 reports
Browse all side effects of Lamictal:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on aripiprazole and lamotrigine (the active ingredients of Aripiprazole and Lamictal, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Acetaminophen vs. Baclofen - 6 seconds ago
- Riboflavin vs. Prozac - 7 seconds ago
- Erleada and Ill-Defined Disorder - 9 seconds ago
- Narcan and Urination - Excessive Volume - 10 seconds ago
- Multivitamin and Hypotonia - 12 seconds ago
- Renagel and Abdominal Abscess - 13 seconds ago
- Lexapro vs. Alcohol - 16 seconds ago
- Monistat 3 and Stools - Watery - 16 seconds ago
- Monistat 3 and Diarrhea - 16 seconds ago
- Verapamil Hydrochloride vs. Cardura - 17 seconds ago